Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Food additive succinate exacerbates experimental autoimmune encephalomyelitis accompanied by increased IL-1β production.
Sugiyama Y, Takata K, Kinoshita M, Motooka D, Shiraishi N, Kihara K, Murata H, Beppu S, Koda T, Yamashita K, Namba A, Fujimoto K, Kumanogoh A, Okuno T, Mochizuki H. Sugiyama Y, et al. Among authors: kihara k. Biochem Biophys Res Commun. 2023 May 14;656:97-103. doi: 10.1016/j.bbrc.2023.03.041. Epub 2023 Mar 16. Biochem Biophys Res Commun. 2023. PMID: 36958260 No abstract available.
High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD).
Beppu S, Kinoshita M, Wilamowski J, Suenaga T, Yasumizu Y, Ogawa K, Ishikura T, Tada S, Koda T, Murata H, Shiraishi N, Sugiyama Y, Kihara K, Sugimoto T, Arase H, Standley DM, Okuno T, Mochizuki H. Beppu S, et al. Among authors: kihara k. Sci Rep. 2022 Jan 7;12(1):106. doi: 10.1038/s41598-021-04074-1. Sci Rep. 2022. PMID: 34997058 Free PMC article.
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder.
Murata H, Kinoshita M, Yasumizu Y, Motooka D, Beppu S, Shiraishi N, Sugiyama Y, Kihara K, Tada S, Koda T, Konaka H, Takamatsu H, Kumanogoh A, Okuno T, Mochizuki H. Murata H, et al. Among authors: kihara k. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 24;9(3):e1149. doi: 10.1212/NXI.0000000000001149. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35210295 Free PMC article.
Switching disease-modifying therapies from sphingosine-1-phosphate receptor modulators to natalizumab or dimethyl fumarate restores immune responses after SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis.
Kanakura M, Kihara K, Kinoshita M, Sugimoto T, Murata H, Beppu S, Shiraishi N, Sugiyama Y, Koda T, Takahashi MP, Chinen I, Okuno T, Mochizuki H. Kanakura M, et al. Among authors: kihara k. Clin Neurol Neurosurg. 2024 Aug;243:108378. doi: 10.1016/j.clineuro.2024.108378. Epub 2024 Jun 15. Clin Neurol Neurosurg. 2024. PMID: 38901377 Free article.
Finding the Right Hepatic Artery Branching from the Gastroduodenal Artery in a Patient Undergoing Gastrectomy: A Rare Case of an Anatomical Variant.
Shimizu S, Matsunaga T, Takahashi T, Sakano Y, Shishido Y, Miyatani K, Kono Y, Murakami Y, Hanaki T, Kihara K, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Hasegawa T, Fujiwara Y. Shimizu S, et al. Among authors: kihara k. Yonago Acta Med. 2024 Sep 15;67(4):355-357. doi: 10.33160/yam.2024.11.002. eCollection 2024 Nov. Yonago Acta Med. 2024. PMID: 39583767 Free PMC article.
Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity.
Kageji H, Momose T, Ebisawa M, Nakazawa Y, Okada H, Togashi N, Nagamoto Y, Obuchi W, Yasumatsu I, Kihara K, Hiramoto K, Minami M, Kasanuki N, Isoyama T, Naito H, Tanaka N. Kageji H, et al. Among authors: kihara k. Bioorg Med Chem. 2024 Sep 1;111:117862. doi: 10.1016/j.bmc.2024.117862. Epub 2024 Jul 30. Bioorg Med Chem. 2024. PMID: 39111073
708 results